EZETIMIBE + ROSUVASTATIN

EZETIMIBE + ROSUVASTATIN

Products
EZETIMIBE + ROSUVASTATIN
EZETIMIBE + ROSUVASTATIN

Information

10mg/5mg, 10mg/10mg, 10mg/15mg, 10mg/20mg, 10mg/30mg, 10mg/40mg tablets, Rosuvastatin/ezetimibe combines two lipid-lowering agents: rosuvastatin, an HMG-CoA reductase inhibitor (i.e. statin) with particularly strong inhibitory effects on hepatic cholesterol synthesis, and ezetimibe, which inhibits the intestinal absorption of cholesterol. ·A fixed-dose combination (FDC) of rosuvastatin/ezetimibe is indicated as an adjunctive therapy to diet for the management of primary hypercholesterolemia in adults.
Distribution Areas
Middle East Region (e.g. UAE)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied From
Poland
All categories
Finished Dosage FormsProducts
Main Categories
Finished Dosage Forms

Log in

See all the content and easy-to-use features by logging in or registering!